Editorial: serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab

被引:1
作者
Appleton, Laura [1 ]
Day, Andrew S. [1 ]
机构
[1] Univ Otago Christchurch, Dept Paediat, Christchurch, New Zealand
关键词
D O I
10.1111/apt.15987
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:1080 / 1081
页数:2
相关论文
共 50 条
  • [21] CLINICAL RELAPSES AND MUCOSAL HEALING IN PATIENTS WITH CROHN'S DISEASE TREATED WITH AZATHIOPRINE
    Morace, F.
    Amalfi, G.
    Caravelli, G.
    Di Pierro, M.
    Schettino, M.
    Verde, C.
    Familiari, V.
    Vespere, G.
    Monastra, S.
    [J]. DIGESTIVE AND LIVER DISEASE, 2011, 43 : S238 - S239
  • [22] Biomarker panel for prediction of mucosal healing in patients with Crohn's disease under infliximab therapy
    de Bruyn, M.
    Bessissow, T.
    Billiet, T.
    Cleynen, I.
    Kirkland, R.
    Liu, X.
    Hauenstein, S.
    Drake, K.
    Singh, S.
    Ferrante, M.
    Rutgeerts, P.
    Van Assche, G.
    Arijs, I.
    Opdenakker, G.
    Vermeire, S.
    [J]. JOURNAL OF CROHNS & COLITIS, 2014, 8 : S45 - S46
  • [23] Biomarker Panel for Prediction of Mucosal Healing in Patients With Crohn's Disease Under Infliximab Therapy
    de Bruyn, Magali
    Bessissow, Talat
    Billiet, Thomas
    Cleynen, Isabelle
    Kirkland, Richard
    Liu, Xinjun
    Hauenstein, Scott
    Drake, Katherine
    Singh, Sharat
    Ferrante, Marc
    Rutgeerts, Paul J.
    Van Assche, Gert A.
    Arijs, Ingrid
    Opdenakker, Ghislain
    Vermeire, Severine
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S428 - S428
  • [24] Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn's Disease Reply
    Dreesen, Erwin
    Gils, Ann
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (01) : 262 - 263
  • [25] Factors Influencing Mucosal Healing in Crohn's Disease during Infliximab Treatment
    Tursi, Antonio
    Elisei, Walter
    Giorgetti, Gian Marco
    Penna, Antonio
    Picchio, Marcello
    Brandimarte, Giovanni
    [J]. HEPATO-GASTROENTEROLOGY, 2013, 60 (125) : 1041 - 1046
  • [26] Visceral Fat Is Associated With Mucosal Healing of Infliximab Treatment in Crohn's Disease
    Shen, Weisong
    Cao, Lei
    Li, Yi
    Cai, Xingchen
    Ge, Yuanyuan
    Zhu, Weiming
    [J]. DISEASES OF THE COLON & RECTUM, 2018, 61 (06) : 706 - 712
  • [27] High Infliximab Trough Levels are Associated With Mucosal Healing in Crohn's Disease
    Van Moerkercke, Wouter
    Ackaert, Chloe
    Compernolle, Griet
    Jurgens, Matthias
    Cleynen, Isabelle
    Van Assche, Gert A.
    Rutgeerts, Paul J.
    Gils, Ann
    Vermeire, Severine
    [J]. GASTROENTEROLOGY, 2010, 138 (05) : S60 - S60
  • [28] Mucosal distribution of infliximab in patients with Crohn's disease (CD).
    Geboes, K
    Dalle, I
    Baert, F
    D'Haens, G
    Cornillie, F
    Rutgeerts, P
    [J]. GASTROENTEROLOGY, 2001, 120 (05) : A322 - A322
  • [29] A MULTI-PROTEIN SERUM TEST PREDICTS MUCOSAL HEALING IN CHILDREN WITH ILEOCOLONIC CROHN'S DISEASE
    Ziring, David
    Singh, Namita
    Arora, Yogesh
    Hester, Kelly D.
    Mimms, Larry
    Jain, Anjali
    Dubinsky, Marla
    Rabizadeh, Shervin
    [J]. GASTROENTEROLOGY, 2019, 156 (06) : S392 - S392
  • [30] Efficacy of infliximab treatment on the mucosal healing of different intestinal segments in patients with ileocolonic Crohn's disease
    Wu, Yaling
    Zhang, Lei
    Cao, Jingli
    Wang, Haichao
    Ye, Chen
    Zhuoma, Deji
    Yang, Pengyu
    Wang, Xiaolei
    [J]. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2020, 13